Galectin Therapeutics (GALT) Stumbles Ahead of Loss

Galectin Therapeutics Inc (NASDAQ: GALT) shares faltered 8.2% to $2.14, as the company is expected to report a quarterly loss at $0.17 per share. Share volume was 571,000, compared to an all-day average of 587,000